Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 21, Issue 2, 2005, Pages 85-91

  Moriyama, T ^a   Matsumoto, T ^a   Jo, Y ^a   Yada, S ^a   Hirahashi, M ^a   Yao, T ^a   Iida, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; FAMOTIDINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; RANTES;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DUODENUM MUCOSA; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUCOSAL IMMUNITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; UREA BREATH TEST;

EID: 20444417817     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02480.x     Document Type: Article

References (35)

1. Haggitt RC, Meissner WA. Crohn's disease of the upper gastrointestinal tract. Am J Clin Pathol 1973; 59: 613-22.
2. Nugent FW, Richmond M, Park SK. Crohn's disease of the duodenum. Gut 1977; 18: 115-20.
3. Rutgeerts P, Onette E, Vantrappen G, et al. Crohn's disease of the stomach and duodenum: a clinical study with emphasis on the value of endoscopic biopsies. Endoscopy 1980; 12: 288-94.
4. Koreliz B, Waye JD, Kreuning J, et al. Crohn's disease in endoscopic biopsies of gastric antrum and duodenum. Am J Gastroenterol 1981; 76: 103-9.
5. Gad A. The diagnosis of gastroduodenal Crohn's disease by endoscopic biopsy. Scand J Gastoenterol Suppl 1989; 167: 23-8.
6. Nugent FW, Roy MA. Duodenal Crohn's disease: an analysis of 89 cases. Am J Gastroenterol 1989; 84: 249-54.
7. Cameron DJS. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease. A prospective study. J Gastrotenterol Hepatol 1991; 6: 355-8.
8. Alcantara M, Rodriguez R, Potenciano JL, et al. Endoscopic and bioptic findings in the upper gastrointestinal tract in patients with Crohn's disease. Endoscopy 1993; 25: 282-6.
9. Lenaerts C, Roy CC, Vaillancourt M, et al. High incidence of upper gastrointestinal tract involvement in children with Crohn's disease. Pediatrics 1989; 83; 777-81.
10. Dancygier H, Frick B. Crohn's disease of upper gastrointestinal tract. Endoscopy 1992; 24: 555-8.
11. Wagtmans MJ, van Hogezand RA, Griffioen G, et al. Crohn's disease of the upper gastrointestinal tract. Neth J Med 1997; 50: S2-7.
12. Yokota K, Saito Y, Einami K, et al. A bamboo joint-like appearance of the gastric body and cardia: possible association with Crohn's disease. Gastrointest Endosc 1997; 46: 268-72.
13. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52.
14. Yoshimura T, Matsushima K, Tanaka S, et al. Purification of a human monocyto-derived neutrophil chemotactic factor that has peptide sequence similary to other host defence cytokines. Proc Natl Acad Sci USA 1987; 84: 9233-7.
15. Kameyoshi Y, Dorschner A, Mallet AI, et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587-92.
16. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45.
17. Brynskov J, Tvede N, Andersen CB, et al. Increased concentrations of iinterleukin-1β, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992; 33: 55-8.
18. Izzo RS, Witkon K, Chen AI, et al. Neutrophil activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scand J gastroenterol 1993; 28: 296-300.
19. McCormack G, Moriarty D, O'Donoghue DP, et al. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001; 50: 491-5.
20. Isomoto H, Mizuta Y, Miyazaki M, et al. Implication of NF-κB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 2000; 95: 2768-76.
21. Noach LA, Bosma NB, Jansen J, et al. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-9.
22. Yamaoka Y, Kita M, Kodama T, et al. Chemokine in the gastric mucosa in Helicobacter pylori infection. Gut 1998; 42: 609-17.
23. Noshiro M, Kusugami K, Sakai T, et al. Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients. Scand J Gastroenterol 2000; 35: 482-9.
24. Isomoto H, Nishi Y, Wang A, et al. Mucosal concentration of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am J Gastroenterol 2004; 99: 1063-8.
25. Wright CL, Riddel RH. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathol 1998; 22: 383-90.
26. Fiocchi G. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
27. Yamada H, Matsukura M, Yudate T, et al. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int Arch All Immunol 1997; 114: 28-32.
28. Daig R, Andus T. Aschenbrenner E, et al. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38: 216-22.
29. Sher ME, D'Angelo AJ, Stein TA, et al. Cytokines in Crohn's colitis. Am J Surg 169; 1995: 133-6.
30. Matsumura M, Matsui T, Hatakeyama S, et al. Prevalence of Helicobacter pylori infection and correlation between severity of upper gastrointestinal lesions and H. pylori infection in Japanese patients with Crohn's disease. J Gastroenterol 2001; 36: 740-7.
31. El-Omar E, Penman I, Cruikshannk G, et al. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulfasalazine. Gut 1994; 35: 1385-8.
32. Miwa T, Miyoshi A. Famotidine in the treatment of gastritis. Scand J Gastroenterol 1987; 22(Suppl. 134): 46-50.
33. Joffe SN, Lee FD, Blumgart LH. Duodenitis. Clin Gastroenterol 1978; 7: 635-50.
34. Nozawa Y, Nishimura K, Akizawa Y, et al. Lafutidine inhibits Helicobacter pylori-induced interleukin-8 production in human gastric epithelial cells. J Gastroenterol Hepatol 2004; 19: 506-11.
35. Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003; 98: 551-6.